News Agency
Men's Weekly

Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND

  • Written by PR Newswire

SHANGHAI, July 19, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 9MW2921 for advanced solid tumor was approved by the National Medical Products Administration (NMPA). 9MW2921 is developed by Mabwell's novel antibody-drug conjugate platef...

Read more: Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND

Defense Industry Jobs and Defence Recruitment: Building Careers That Shape National Security

The defence sector is one of the most important contributors to national security, innovation, and economic growth. Across Australia and worldwide, defense industry jobs offer opportunities for individuals to work in fields that combine technology, strategy, and service to the nation... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion